219 related articles for article (PubMed ID: 8348704)
1. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.
Hamdi I; Green M; Shneerson JM; Palmer CR; Hales CN
Clin Endocrinol (Oxf); 1993 Jul; 39(1):21-6. PubMed ID: 8348704
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.
Holl RW; Wolf A; Thon A; Bernhard M; Buck C; Missel M; Heinze E; von der Hardt H; Teller WM
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):188-93. PubMed ID: 9252906
[TBL] [Abstract][Full Text] [Related]
3. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
[TBL] [Abstract][Full Text] [Related]
4. [Carbohydrate metabolic changes in cystic fibrosis].
García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
[TBL] [Abstract][Full Text] [Related]
5. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
6. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
7. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.
Davies MJ; Rayman G; Gray IP; Day JL; Hales CN
Diabet Med; 1993 May; 10(4):313-20. PubMed ID: 8508612
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Nerup J; Koch C
Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.
Conway GS; Clark PM; Wong D
Clin Endocrinol (Oxf); 1993 Feb; 38(2):219-22. PubMed ID: 8435903
[TBL] [Abstract][Full Text] [Related]
12. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
[TBL] [Abstract][Full Text] [Related]
13. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
Diabet Med; 1994 Apr; 11(3):293-8. PubMed ID: 8033529
[TBL] [Abstract][Full Text] [Related]
15. True insulin and intact proinsulin levels in acromegalic patients.
Tavares EF; Dalbosco IS; Abucham J; Russo EM
Eur J Endocrinol; 1996 May; 134(5):549-53. PubMed ID: 8664973
[TBL] [Abstract][Full Text] [Related]
16. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
Persson B; Hanson U; Hartling SG; Binder C
Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
[TBL] [Abstract][Full Text] [Related]
18. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
19. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
[TBL] [Abstract][Full Text] [Related]
20. Fasting proinsulin concentrations predict the development of type 2 diabetes.
Wareham NJ; Byrne CD; Williams R; Day NE; Hales CN
Diabetes Care; 1999 Feb; 22(2):262-70. PubMed ID: 10333943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
